Herpes Simplex -Epidemiology Forecast to 2027

  • ID: 4520729
  • Report
  • 70 pages
  • DelveInsight
1 of 3
This report titled ‘Herpes Simplex Virus (HSV) Infections- Epidemiology Forecast to 2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of HSV infections in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Geography Covered:
  • The United States
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan
Study Period: 2016-2027

HSV infections Epidemiology

The HSV Infections epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. The epidemiology data for HSV Infections are studied through all possible division to give a better understanding about the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

HSV Infections Epidemiology Segmentation

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [total prevalent cases, prevalent cases by types (Genital Herpes and Herpes Labialis), diagnosed prevalence] of HSV infections in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.

The report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

According to this research, total prevalent population of HSV infections in 7 major markets was estimated to be about 228,552,199 in 2016.

Report Scope:
  • The report covers detailed overview of HSV infections explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The report provides the insight about the historical and forecasted patient pool of HSV infections in 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Report assesses the disease risk and burden and highlights the unmet needs of the disease
  • The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report provides the segmentation of the disease epidemiology by types and diagnosed prevalent cases of HSV infections in 7MM
Key Strengths:
  • 10 Year Forecast of HSV infections epidemiology
  • 7MM Coverage
  • Total Prevalent Cases of HSV infections
  • Prevalent Cases according to segmentation: HSV infections by clinical types (Genital Herpes and Herpes Labialis) in 7MM
  • Diagnosed cases of HSV infections
Key Assessments:
  • Patient Segmentation
  • Disease Risk & Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Key Insights

2. Disease Background and Overview: Herpes Simplex Virus (HSV)
2.1. Introduction
2.2. Stages of Herpes infection
2.3. Clinical manifestations
2.4. Risk Factors
2.5. Disease Causes
2.6. HSV-Symptoms
2.7. Pathogenesis
2.8. HSV Diagnosis

3. Epidemiology and Patient Population

4. Key Findings
4.1. Disease Definition
4.2. Population and Forecast Parameters
4.3. 7MM Prevalent Population of Herpes Simplex Virus (HSV)
4.4. 7MM Type-Specific Prevalent Population of Herpes Simplex Virus (HSV)

5. Country Wise-Epidemiology of Herpes Simplex Virus (HSV)
5.1. United States
5.1.1. Prevalent Population of HSV in the United States
5.1.2. Type-Specific HSV Prevalence in the United States
5.1.3. Diagnosed Cases of HSV in the United States
5.2. Germany
5.2.1. Prevalent Population of HSV in Germany
5.2.2. Type-Specific HSV Prevalence in Germany
5.2.3. Diagnosed Cases of HSV in Germany
5.3. France
5.3.1. Prevalent Population of HSV in France
5.3.2. Type-Specific HSV Prevalence in France
5.3.3. Diagnosed Cases of HSV in France
5.4. Italy
5.4.1. Prevalent Population of HSV in Italy
5.4.2. Type Specific HSV prevalence in Italy
5.4.3. Diagnosed cases of HSV in Italy
5.5. Spain
5.5.1. Prevalent Population of HSV in Spain
5.5.2. Type Specific HSV prevalence in Spain
5.5.3. Diagnosed cases of HSV in Spain
5.6. United Kingdom
5.6.1. Prevalent cases of HSV in the UK
5.6.2. Type Specific HSV prevalence in the UK
5.6.3. Diagnosed cases of HSV in the UK
5.7. Japan
5.7.1. Prevalent cases of HSV in Japan
5.7.2. Type Specific HSV prevalence in Japan
5.7.3. Diagnosed cases of HSV in Japan

6. Market Drivers of HSV

7. Market Barriers of HSV

8. Appendix

9. Report Methodology
9.1. Sources Used

10. Capabilities

11. Disclaimer

12. About the Publisher

List of Tables
Table 1: Prevalent Population of HSV in the 7MM (2016-2027)
Table 2: 7MM Type-Specific Prevalent Population of HSV (2016-2027)
Table 3: Prevalent Population of HSV in the United States (2016-2027)
Table 4: Type-Specific HSV Prevalence in the United States (2016-2027)
Table 5: Diagnosed Cases of HSV in the United States (2016-2027)
Table 6: Prevalent Population of HSV in Germany (2016-2027)
Table 7: Type-Specific HSV Prevalence in Germany (2016-2027)
Table 8: Diagnosed Cases of HSV in Germany (2016-2027)
Table 9: Prevalent Population of HSV in France (2016-2027)
Table 10: Type-Specific HSV Prevalence in France (2016-2027)
Table 11: Diagnosed Cases of HSV in France (2016-2027)
Table 12: Prevalent Population of HSV in Italy (2016-2027)
Table 13: Type-Specific HSV Prevalence in Italy (2016-2027)
Table 14: Diagnosed Cases of HSV in Italy (2016-2027)
Table 15: Prevalent Population of HSV in Spain (2016-2027)
Table 16: Type-Specific HSV Prevalence in Spain (2016-2027)
Table 17: Diagnosed Cases of HSV in Spain (2016-2027)
Table 18: Prevalent Population of HSV in the UK (2016-2027)
Table 19: Type-Specific HSV Prevalence in the UK (2016-2027)
Table 20: Diagnosed Cases of HSV in the UK (2016-2027)
Table 21: Prevalent Population of HSV in Japan (2016-2027)
Table 22: Type-Specific HSV Prevalence in Japan (2016-2027)
Table 23: Diagnosed Cases of HSV in Japan (2016-2027)

List of Figures
Figure 1: Stages of Herpes infection
Figure 2: Clinical manifestations of Herpes infection
Figure 3: Risk factors associated with Herpes Simplex
Figure 4: Blisters
Figure 5: (a) Primary infection (b) Recurrent infection
Figure 6: Life Cycle of HSV infection
Figure 7: Establishment of primary infection
Figure 8: Prevalent Population of HSV in the 7MM (2016-2027)
Figure 9: 7MM Type-Specific Prevalent Population of HSV (2016-2027)
Figure 10: Prevalent Population of HSV in the United States (2016-2027)
Figure 11: Type-specific HSV Prevalence in the United States (2016-2027)
Figure 12: Diagnosed Cases of HSV in the United States (2016-2027)
Figure 13: Prevalent Population of HSV in Germany (2016-2027)
Figure 14: Type-specific HSV Prevalence in Germany (2016-2027)
Figure 15: Diagnosed Cases of HSV in Germany (2016-2027)
Figure 16: Prevalent Population of HSV in France (2016-2027)
Figure 17: Type-specific HSV Prevalence in France (2016-2027)
Figure 18: Diagnosed Cases of HSV in France (2016-2027)
Figure 19: Prevalent Population of HSV in Italy (2016-2027)
Figure 20: Type-specific HSV Prevalence in Italy (2016-2027)
Figure 21: Diagnosed Cases of HSV in Italy (2016-2027)
Figure 22: Prevalent Population of HSV in Spain (2016-2027)
Figure 23: Type-specific HSV Prevalence in Spain (2016-2027)
Figure 24: Diagnosed Cases of HSV in Spain (2016-2027)
Figure 25: Prevalent Population of HSV in the UK (2016-2027)
Figure 26: Type-specific HSV Prevalence in the UK (2016-2027)
Figure 27: Diagnosed Cases of HSV in the UK (2016-2027)
Figure 28: Prevalent Population of HSV in Japan (2016-2027)
Figure 29: Type-specific HSV Prevalence in Japan (2016-2027)
Figure 30: Diagnosed Cases of HSV in Japan (2016-2027)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll